PATENT CLAIM ANALYSIS

Application Number: 16079649
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "528000"]

Abstract:
Disclosed herein are chemotherapeutic methods for the treatment of cancer in humans. In at least one specific embodiment, the method can include administering a therapeutic effective amount of one or more p38 inhibitor compound or salt thereof to a human. The method can also include administering a therapeutic effective of one or more IL-6 inhibitor or one or more IL-6 receptor inhibitor or salt thereof to the human. The method can also include administering a therapeutic effective amount of one or more cytotoxic compound or salt thereof to the human.

Claim (Index 11):
The method of  claim 10 , wherein the IL-6 inhibitor or the IL-6R inhibitor inhibits the activity and/or the expression of IL-6 or IL-6R.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 96.0
- Lexical Diversity: 2.2619
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13806929', '13586814', '14306784', '15417740', '13455972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7375353840045812
- 35 USC 102 Novelty (BERT): 0.5271133162696074
- Combined Prediction Score: 0.7164931772310839
- Mean Citation Score: 234.121338
- Max Citation Score: 267.1895
- Similarity Product: 130.06993090899292

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test